Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains?

Stoke Therapeutics, Inc. (STOK) shares soared 11.7% in the last trading session to close at $30.5. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 23.7% gain over the past four weeks.The price rise can be attributed to growing investor confidence related to Stoke Therapeutics’ efforts in developing lead candidate, zorevunersen, as a first-in-class potential disease-modifying therapy for Dravet syndrome. Earlier this week, the com ...